Prifuroline is a chemical compound classified as a selective serotonin reuptake inhibitor (SSRI) and is primarily studied for its potential therapeutic effects in treating various psychiatric disorders. It is characterized by its unique molecular structure, which includes a furoline moiety, contributing to its pharmacological properties. The compound exhibits a moderate affinity for serotonin transporters, leading to increased serotonin levels in the synaptic cleft, which can enhance mood and alleviate symptoms of depression and anxiety. Prifuroline's mechanism of action involves the inhibition of serotonin reuptake, thereby prolonging the action of serotonin in the brain. Additionally, it may possess other pharmacological effects, including potential neuroprotective properties. As with many SSRIs, the side effect profile can include gastrointestinal disturbances, changes in weight, and potential withdrawal symptoms upon discontinuation. Research into Prifuroline continues to explore its efficacy, safety, and potential applications in clinical settings, making it a compound of interest in the field of psychopharmacology.

Prifuroline

70833-07-7: Prifuroline [INN], Prifurolina, Prifurolina [INN-Spanish], Prifurolinum, Prifurolinum [INN-Latin], Unii-Op2V3Xrv2Y, 4-(2-Benzofuranyl)-2-(dimethylamino)-1-pyrroline, 3-(1-benzofuran-2-yl)-N,N-dimethyl-3,4-dihydro-2H-pyrrol-5-amine

Please enquire for more information about Prifuroline including the price, delivery time and more detailed product information at the technical inquiry form on this page

Prifuroline is an agent of antiarrhythmic.

CAS 70833-07-7: Prifuroline

Prifuroline

Ref: 3D-VCA83307

Prifuroline

Ref: TM-T12538